Biohaven Pharmaceutical Holding Company Ltd (NYSE:BHVN)
| 84.91 Delayed Data As of Jan 15 |  -6.84 / -7.46%Today’s Change | 26.56 Today|||52-Week Range 100.77 | -0.93% Year-to-Date |
Latest BHVN News | Press Releases
No recent news for Biohaven Pharmaceutical Holding Company Ltd.
Today’s Trading
| Previous close | 91.75 |
| Today’s open | 91.24 |
| Day’s range | 84.47 - 92.39 |
| Volume | 48,103 |
| Average volume (3 months) | 532,763 |
| Market cap | $5.1B |
Data as of 3:59pm ET, 01/15/2021
Growth & Valuation
| Earnings growth (last year) | -77.39% |
| Earnings growth (this year) | -12.50% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GRFSGrifols SA | -0.07 | -0.37% |
| HCMHutchison China Medi... | -1.18 | -3.37% |
| SAGESAGE Therapeutics In... | -5.38 | -5.56% |
| ARNAArena Pharmaceutical... | -0.06 | -0.07% |
Data as of 4:00pm ET, 01/15/2021
Financials
| Next reporting date | March 3, 2021 |
| EPS forecast (this quarter) | -$2.94 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$528.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New Haven, Connecticut |
Forecasts
